STTKShattuck Labs, Inc.
Pharmaceutical Preparations
- Revenue
- $1M
- 83% YoY
- Operating margin
- -5150.8%
- 266% YoY
- EBITDA
- −$48M
- 38% YoY
- Market cap
- $560M
- Employees
- —
- Net debt / EBITDA
- —
- AI in 10-K
- 0.5
- mentions per 10K words
Takeover score 3 of 13
Fixable underperformance 1 of 7
- TSR below peersNo—3+ of last 5 years
- High CEO pay despite TSRNo$2M medianMedian CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo—Cash flow under 80% of net income
- Dilutive SBCYes700% of revenueOver 10% of revenue
- Payouts exceed cash flowNo0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyNo—Over 40% of assets
- Shareholder dissentNo92% lowest supportAny vote under 80% support
Buyer economics 2 of 4
- Low revenue per employeeNo—Bottom quartile of its SIC industry
- Quiet on AIYes0.5 per 10K words · 23rd pctBottom quartile of AI mentions in 10-Ks
- Net cashNo—More cash than debt, positive EBITDA
- Buyout-sizedYes$560M market capMarket cap $500M–$5B
Catalysts 0 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingNo−$342K netNet sales over $10M in 12 months
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $30M | $652K | $2M | $6M | $1M | 83% |
| Operating income | −$45M | −$103M | −$92M | −$81M | −$52M | 36% |
| Net income | −$45M | −$102M | −$87M | −$75M | −$49M | 35% |
| Operating cash flow | −$57M | −$94M | −$81M | −$61M | −$40M | 34% |
| Capex | $8M | $12M | $407K | $59K | $71K | 20% |
| Stock-based comp | $5M | $6M | $7M | $10M | $7M | 27% |
Deal filings
None.
13D filers
| Filed | Filer | Form | Stake | Intent |
|---|---|---|---|---|
| Jul 17, 2026 | Redmile Group, LLC | SCHEDULE 13D/A | 9.9% | Passive |
| Jun 15, 2026 | ORBIMED ADVISORS LLC | SCHEDULE 13D/A | 10.0% | Passive |
| Jun 11, 2026 | Redmile Group, LLC | SCHEDULE 13D/A | 9.9% | Passive |
| Sep 2, 2025 | ORBIMED ADVISORS LLC | SCHEDULE 13D | 10.0% | Passive |
| Aug 26, 2025 | Redmile Group, LLC | SCHEDULE 13D/A | 9.9% | Passive |
| Aug 6, 2025 | Redmile Group, LLC | SCHEDULE 13D/A | 11.8% | Passive |
| Dec 6, 2024 | Redmile Group, LLC | SC 13D/A | 11.8% | Passive |
| Dec 26, 2023 | Redmile Group, LLC | SC 13D/A | 12.0% | Passive |
| Dec 9, 2022 | Hornblower Josiah | SC 13D/A | 7.0% | Passive |
| Oct 23, 2020 | Hornblower Josiah | SC 13D | 8.2% | Passive |
Insider trading
- Open-market buys, 12 mo
- $250K · 1
- Open-market sells, 12 mo
- $592K · 6
- Net
- −$342K
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | $2M | $3M | 51 | — |
| FY2024 | $3M | $1M | 17 | — |